Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 211-220 of 684 for cancer

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A First-in-Human (FIH) Study To Evaluate The Safety And Tolerability Of VVD-159642 In Participants With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ

  2. Lead-212 PSV359 Therapy For Patients With Solid Tumors

    Rochester, MN

  3. A Study Of A Selective ERBB2 Inhibitor (CGT4255), In Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Turkey Tail Mushroom For Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery

    Scottsdale/Phoenix, AZ

  5. Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed By Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance In Treatment-Naïve Mantle Cell Lymphoma

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. A Study Of NT-175 In Adult Participants With Advanced Malignancies That Are Positive For HLA-A*02:01 And The TP53 R175H Mutation

    Jacksonville, FL

  7. A Study Of LY4152199 In Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

    Rochester, MN

  8. Study Of KITE-363 Or KITE-753 In Participants With Relapsed And/or Refractory B-cell Lymphoma

    Jacksonville, FL, Rochester, MN

  9. Study Of AZD5863 In Adult Participants With Advanced Or Metastatic Solid Tumors

    Jacksonville, FL, Rochester, MN

  10. Comparing Rituximab And Mosunetuzumab Drug Treatments For People With Low Tumor Burden Follicular Lymphoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer